Oncology Care Pathways Supporting the Use of High-value Treatments for NSCLC

Supplements and Featured Publications, Oncology Care Pathways Supporting the Use of High-value Treatments for NSCLC,

This AJMC® publication explores the value of clinical oncology care pathways in non–small cell lung cancer (NSCLC) with insights from Edward Arrowsmith, MD, Medical Director for Pathways at OneOncology in Chattanooga, Tennessee.